Patent ID: 9493485
Filing Date: 2016-11-15
CPC Classification: A61P,C07D

Claim Text:
1. A method of treating a neurodegenerative disease, the method comprising: administering to a mammalian subject in need thereof a pharmaceutically effective amount of a compound having a structure according to Formula I: or a pharmaceutically accept able salt thereof, wherein: Y is S; L is selected from the group consisting of a direct bond, —CR A A A R R R R R L R R R R R R R m is 0, 1, or 2; n is 0, 1, 2, or 3; p is 0, 1, 2, or 3; and z is 0, 1, or 2, and wherein the disease is associated with Aβ peptide aggregation, oligomerization, fibrillization, or plaque formation.